Why did these ASX shares outperform their peers in 2025?

Did you snap up any of these stocks this year?

Key points
  • ASX materials and defence shares soared in 2025 due to rising commodity prices and increased global defence investment, despite a modest overall market gain of 6%.
  • Two of the healthcare sector's top performers were 4DMedical and Racura Oncology, which defied broader sector struggles. 
  • Despite tech sector challenges, Elsight and Energy One surged thanks to major contracts and strong financial growth.

It has been a modest year for the S&P/ASX 200 Index (ASX: XJO) in 2025, with an approximate gain of 6%. ASX materials and defence shares have been a real winner thanks to soaring commodity prices and global defence investment. 

On the flip side, it's been a tough year for Australian technology and healthcare shares. 

The S&P/ASX All Technology Index (ASX: XTX) has dropped almost 11% in 2025, including more than 20% since October. 

Similarly, the S&P/ASX 200 Health Care Index (ASX: XHJ) is down more than 24% since January. 

But amidst these struggling sectors have been some diamonds in the rough. 

Let's look at some of the winners from these two sectors in 2025. 

A team celebrates a win in the office.

Image source: Getty Images

Healthcare winners

One of the best performing ASX shares in 2025 has been 4DMedical Ltd (ASX: 4DX). 

The medical technology company works in the field of respiratory imaging and ventilation analysis in the treatment of lung and respiratory diseases.

The Motley Fool's Aaron Teboneras reported earlier this month on the consistent run of positive results and milestones hit by the company this year. 

Regulatory approvals and new commercial partnerships have expanded its markets and validated its technology, shifting investor views from speculative potential to increasingly visible and growing software revenue.

This has launched the stock almost 680% higher in 2025. 

Despite this unbelievable run, it's still drawing optimism for future growth.

Another healthcare stock winner this year has been Racura Oncology Ltd (ASX: RAC). 

It is an Australian clinical-stage biopharmaceutical company focused on developing cancer treatments.

It has risen almost 100% in 2025, meaning investors almost doubled their returns holding this stock through the year. 

This has been driven by promising scientific research and private placement offers.

Technology winners

Meanwhile, in the technology sector, one of the best-performing ASX shares has been Elsight Ltd (ASX: ELS). 

The company technically sits in the information technology sector, but has risen thanks to tailwinds in the defence sector. 

The company offers advanced communication components for unmanned systems (aerial, ground, and sea) through its flagship product – the Halo platform. 

Its rise has been fuelled by major contract wins, including a US$21.2M contract for CY2026. 

CY25e also marked a pivotal inflection point for the company, achieving profitability and delivering estimated revenue growth of 12x YoY (BPe). 

Its share price has risen by more than 750% this year. 

Finally, another technology stock that has enjoyed a stellar year is Energy One Ltd (ASX: EOL). 

It is a supplier of software products and services to wholesale energy, environmental, and carbon trading markets.

It reported strong growth in the 2025 financial year, reporting revenue growth of 17% to $61.4 million and annual recurring revenue (ARR) rising 22% to $60.4 million.

Its share price is up more than 150% this year. 

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Energy One. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

A young woman checks her investments on her tablet.
ASX Share Market News

The Vanguard ETFs I'd buy first if I were starting again

Paired together, they're about as sensible a starting point as it gets.

Read more »

A jockey gets down low on a beautiful race horse as they flash past in a professional horse race with another competitor and horse a little further behind in the background.
Broker Notes

RBC Capital Markets thinks Tabcorp shares could go how high?

These shares are looking like a good bet.

Read more »

Woman holding her glasses and looking at her laptop.
Broker Notes

Down 65%: Is it a good time to buy this exciting ASX tech stock?

Bell Potter has given its view on this stock after a significant pullback.

Read more »

Man working on a laptop from home.
Broker Notes

Is this ASX 200 share a bargain after crashing to $12?

Bell Potter has given its verdict on this beaten down stock.

Read more »

A panel of formidable business people stand in a group with serious looks on their faces as if in judgement of what's before them.
Broker Notes

Buy, hold, sell: Regal Partners, HomeCo Daily Needs REIT, APA Group shares

We review three fresh buy, hold, and sell calls from expert market analysts. 

Read more »

Happy female accountant looking at her tablet.
ASX Share Market News

5 things to watch on the ASX 200 on Wednesday

Will it be a good session for Aussie investors? Let's find out.

Read more »

Buy and sell written on red dice on top of stock market charts.
Broker Notes

Up 98%: Are CSL shares now a buy, hold or sell?

A leading expert provides his forecast for CSL’s rocketing shares.

Read more »

Girl with painted hands.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy Tuesday for investors.

Read more »